| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/04/2015 | CN102875674B 一种抗破伤风毒素抗体及其制备方法和用途 An anti-tetanus toxin antibodies and their preparation and use |
| 02/04/2015 | CN102731651B 针对肠球菌和金黄色葡萄球菌具有杀伤活性的人结合分子及其应用 People against enterococci and Staphylococcus aureus killing activity binding molecules and its applications |
| 02/04/2015 | CN102012433B 禽流感病毒h9亚型阳性血清和阴性血清标准物质及制备方法 H9 subtypes of avian influenza virus positive serum and negative serum reference materials and preparation methods |
| 02/04/2015 | CN101928334B 一种鼠Ehf多肽及其抗体制备方法 A murine antibody preparation Ehf polypeptides and methods |
| 02/04/2015 | CN101918438B 新颖蛋白质 Novel protein |
| 02/03/2015 | US8946395 Purification of proteins using hydrophobic interaction chromatography |
| 02/03/2015 | US8946392 Gemcitabine immunoassay |
| 02/03/2015 | US8946391 Construction of a multivalent scFv through alkyne-azide 1,3-dipolar cycloaddition |
| 02/03/2015 | US8946390 Cancer-associated antigen |
| 02/03/2015 | US8946388 Monoclonal antibodies for treatment of cancer |
| 02/03/2015 | US8946387 FcγRIIB specific antibodies and methods of use thereof |
| 02/03/2015 | US8946385 Chimeric Fcγ receptor and method for determination of ADCC activity by using the receptor |
| 02/03/2015 | US8946382 Apelin peptides and methods of use |
| 02/03/2015 | US8946380 Liposome allowing liposome-entrapped substance to escape from endosome |
| 02/03/2015 | US8946156 Albumin Fusion Proteins |
| 02/03/2015 | US8946146 Method for modulating appetite |
| 02/03/2015 | US8945878 Methods for identifying and isolating cells expressing a polypeptide |
| 02/03/2015 | US8945877 Polynucleotides encoding BMP-ALK3 antagonists |
| 02/03/2015 | US8945874 Polynucleotides encoding NOTCH1 receptor antibodies |
| 02/03/2015 | US8945873 Polynucleotides encoding Notch receptor antibodies |
| 02/03/2015 | US8945871 Anti-IGF-IR antibodies and uses thereof |
| 02/03/2015 | US8945870 DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 02/03/2015 | US8945867 Process for producing polypeptide |
| 02/03/2015 | US8945860 Highly sensitive monoclonal antibody residual detection assay |
| 02/03/2015 | US8945857 Methods of isolating cells and generating monoclonal antibodies |
| 02/03/2015 | US8945588 Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| 02/03/2015 | US8945571 Targeted immunoconjugates |
| 02/03/2015 | US8945570 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/03/2015 | US8945569 Jagged-binding agents and uses thereof |
| 02/03/2015 | US8945568 Pneumococcal Serotype 6D |
| 02/03/2015 | US8945567 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| 02/03/2015 | US8945565 Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies |
| 02/03/2015 | US8945564 Antagonist anti-CD40 antibody pharmaceutical compositions |
| 02/03/2015 | US8945563 Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 02/03/2015 | US8945562 Anti-complement C1s antibodies |
| 02/03/2015 | US8945561 Receptor modulators |
| 02/03/2015 | US8945559 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies |
| 02/03/2015 | US8945558 Methods for treating myocardial infarction comprising administering an IL-6 inhibitor |
| 02/03/2015 | US8945557 Use of immunesuppressant receptor |
| 02/03/2015 | US8945555 Inotropic antibodies and therapeutic uses thereof |
| 02/03/2015 | US8945554 Class I anti-CEA antibodies and uses thereof |
| 02/03/2015 | US8945553 Bispecific antibodies to IL-23 and IL-17A/F |
| 02/03/2015 | US8945552 Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies |
| 02/03/2015 | US8945549 Methods of treating antinociceptive tolerance |
| 02/03/2015 | US8945548 Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders |
| 02/03/2015 | US8945547 Notch1 receptor antibodies and methods of treatment |
| 02/03/2015 | US8945546 IP-10 antibodies and their uses |
| 02/03/2015 | US8945545 Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23 |
| 02/03/2015 | US8945543 Stabilizer for protein preparation comprising meglumine and use thereof |
| 02/03/2015 | US8945541 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases |
| 02/03/2015 | CA2800113C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 02/03/2015 | CA2775793C Siglec 15 antibodies in treating bone loss-related disease |
| 02/03/2015 | CA2768745C Beta cell marker antibody |
| 02/03/2015 | CA2722378C Human antibodies that bind tnf.alpha. |
| 02/03/2015 | CA2661848C Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 02/03/2015 | CA2632552C Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use |
| 02/03/2015 | CA2623530C Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 02/03/2015 | CA2583417C Antagonists and methods of use therefor |
| 02/03/2015 | CA2519620C Humanized anti-cd4 antibody with immunosuppressive properties |
| 02/03/2015 | CA2492377C Recombinant production of mixtures of antibodies |
| 02/03/2015 | CA2465009C Cytotoxin with a subtilase domain |
| 02/03/2015 | CA2436671C Rationally designed antibodies |
| 01/29/2015 | WO2015013671A1 Multispecific antibodies, multispecific activatable antibodies and methods of using the same |
| 01/29/2015 | WO2015013668A1 Anti-immunoglobulin e antibodies and methods of use thereof |
| 01/29/2015 | WO2015013390A1 Anti-hiv dual specificity antibodies and methods of hiv treatment |
| 01/29/2015 | WO2015012944A1 Methods and compositions for increasing enzyme activity in the cns |
| 01/29/2015 | WO2015011660A1 Methods for controlling fucosylation levels in proteins |
| 01/29/2015 | WO2015011658A1 Use of a cd6 binding partner and method based thereon |
| 01/29/2015 | WO2015011199A1 Stabilized antibody compositions |
| 01/29/2015 | WO2015010792A1 Antibodies that potently neutralize rsv and uses thereof |
| 01/29/2015 | WO2015010791A2 Novel antibodies for the diagnosis and treatment of rheumatoid arthritis |
| 01/29/2015 | WO2015010347A1 Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus e6 protein |
| 01/29/2015 | US20150033417 Promoter, promoter control elements, and combinations, and uses thereof |
| 01/29/2015 | US20150033372 Human VpreB & Chimaeric Surrogate Light Chains in Transgenic Non-Human Vertebrates |
| 01/29/2015 | US20150033369 Animals, repertoires & methods |
| 01/29/2015 | US20150031870 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 01/29/2015 | US20150031862 OPTIMIZED Fc VARIANTS |
| 01/29/2015 | US20150031861 Chemical Modification of Antibodies |
| 01/29/2015 | US20150031860 Human antibodies and proteins |
| 01/29/2015 | US20150031748 Modulating the interaction between zo-2/tjp2 and a snail zinc finger transcription factor family member |
| 01/29/2015 | US20150031624 Anti-mesothelin chimeric antigen receptors |
| 01/29/2015 | US20150031604 Cyclic polypeptides for the treatment of heart failure |
| 01/29/2015 | US20150031563 Multi Component Antibody Based Detection Technology |
| 01/29/2015 | US20150031550 Human antibodies and proteins |
| 01/29/2015 | US20150031081 Methods and materials for reducing degradation of recombinant proteins |
| 01/29/2015 | US20150031056 Development of specific immunoassay critical reagents for pharmacokinetic assessments of peptide polymers in preclinical and clinical matrices |
| 01/29/2015 | US20150031055 Novel bioactive lipid derivatives, and methods of making and using the same |
| 01/29/2015 | US20150031025 Genetic products differentially expressed in tumors and use thereof |
| 01/29/2015 | US20150030618 Novel binder-drug conjugates (adcs) and use thereof |
| 01/29/2015 | US20150030614 Antibodies to the pcrv antigen of pseudomonas aeruginosa |
| 01/29/2015 | US20150030613 Treatment of mucositis with immunoglobulin |
| 01/29/2015 | US20150030612 Immunization against clostridium difficile disease |
| 01/29/2015 | US20150030611 Monitoring and Modulating HGF/HGFR Activity |
| 01/29/2015 | US20150030609 Diagnosis and treatment of traumatic brain injury |
| 01/29/2015 | US20150030608 Method of Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 01/29/2015 | US20150030607 Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection |
| 01/29/2015 | US20150030606 Actriib binding agents and uses thereof |
| 01/29/2015 | US20150030605 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 01/29/2015 | US20150030604 Method of blocking vascular leakage using an anti-ang2 antibody |
| 01/29/2015 | US20150030603 Anti-ang2 antibody |